Dean Capital Management Makes New Investment in Avantor, Inc. $AVTR

Dean Capital Management purchased a new stake in Avantor, Inc. (NYSE:AVTR) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 92,349 shares of the company’s stock, valued at approximately $1,153,000.

Several other large investors also recently made changes to their positions in AVTR. Sector Gamma AS lifted its stake in Avantor by 28.0% during the third quarter. Sector Gamma AS now owns 477,104 shares of the company’s stock valued at $5,954,000 after purchasing an additional 104,466 shares during the last quarter. Greenhaven Associates Inc. acquired a new position in Avantor in the third quarter worth approximately $228,528,000. Natixis Advisors LLC increased its holdings in shares of Avantor by 124.8% in the third quarter. Natixis Advisors LLC now owns 1,907,077 shares of the company’s stock valued at $23,800,000 after buying an additional 1,058,617 shares in the last quarter. Quantbot Technologies LP increased its holdings in shares of Avantor by 1,333.0% in the third quarter. Quantbot Technologies LP now owns 246,494 shares of the company’s stock valued at $3,076,000 after buying an additional 229,293 shares in the last quarter. Finally, Voss Capital LP acquired a new stake in shares of Avantor during the 2nd quarter valued at $6,057,000. Institutional investors own 95.08% of the company’s stock.

Insider Buying and Selling

In other Avantor news, Director Gregory L. Summe acquired 100,000 shares of Avantor stock in a transaction that occurred on Thursday, February 12th. The stock was purchased at an average cost of $9.40 per share, with a total value of $940,000.00. Following the purchase, the director owned 400,000 shares in the company, valued at approximately $3,760,000. The trade was a 33.33% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Gregory T. Lucier acquired 50,000 shares of the firm’s stock in a transaction on Thursday, February 19th. The shares were acquired at an average price of $9.16 per share, with a total value of $458,000.00. Following the completion of the transaction, the director directly owned 50,000 shares in the company, valued at approximately $458,000. This trade represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders acquired 275,000 shares of company stock valued at $2,399,250. Corporate insiders own 1.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on AVTR. Morgan Stanley set a $10.00 price objective on Avantor in a research note on Friday, February 13th. Evercore set a $10.00 target price on Avantor in a report on Wednesday, February 11th. Robert W. Baird set a $11.00 price target on Avantor in a research report on Thursday, February 12th. Citigroup dropped their price target on Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a research note on Thursday, February 12th. Finally, Stifel Nicolaus set a $10.00 price objective on Avantor in a report on Thursday, February 12th. Three analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, Avantor has a consensus rating of “Hold” and a consensus price target of $11.80.

Avantor Trading Up 0.5%

NYSE AVTR opened at $7.94 on Monday. The firm’s 50 day moving average price is $10.36 and its two-hundred day moving average price is $11.66. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.18 and a current ratio of 1.78. Avantor, Inc. has a twelve month low of $7.82 and a twelve month high of $17.11. The stock has a market cap of $5.41 billion, a price-to-earnings ratio of -10.18, a PEG ratio of 3.11 and a beta of 0.97.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. The company had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.64 billion. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.The company’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.27 earnings per share. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. Equities analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current year.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.